Indian Society of Vascular and Interventional Radiology Expert Consensus Statements for Ablation in Hepatocellular Carcinoma: Part I

Author:

Gupta Pankaj1ORCID,Kalra Naveen1,Keshava Shyamkumar N.2,Chaluvashetty Sreedhara B.1,Mukund Amar3,Roy-Choudhury Shuvro H.4,Baijal Sanjay Saran5,Khandelwal Anubhav5,Ananthashayana Venkatesh Hosur3,R. Sathya Narayanan2,Kulkarni Suyash6,Shetty Nitin Sudhakar6,Gupta Arun7,Gupta Sanjay8

Affiliation:

1. Department of Radiodiagnosis and Imaging, Postgraduate Institute of Medical Education and Research, Chandigarh, India

2. Department of Interventional Radiology, Division of Clinical Radiology, Christian Medical College, Vellore, Tamil Nadu, India

3. Department of Interventional Radiology, Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

4. Department of Radiology, NH Group of Hospitals, Kolkata, West Bengal, India

5. Department of Interventional Radiology, Medanta, The Medicity, Gurgaon, Haryana, India

6. Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India

7. Department of Interventional Radiology, Sir Ganga Ram Hospital, New Delhi, Delhi, India

8. Department of Interventional Radiology, MD Anderson Cancer Center, Houston, Texas, United States

Abstract

AbstractLocoregional therapies play an important role in the management of hepatocellular carcinoma (HCC). Percutaneous ablation is one of the most commonly employed nonsurgical methods for treating very early and early HCC. For small HCCs, ablation is potentially curative and competes with surgical resection. The widespread availability and the spectrum of ablative techniques mandate uniform approach among interventional radiologists. Thus, it is desirable to have a consensus regarding various aspects of liver ablation. This article represents a consensus document of the experts from the Indian Society of Vascular and Interventional Radiology involved in the care of patients with HCC. The statements are presented in two parts.

Publisher

Georg Thieme Verlag KG

Subject

Radiology, Nuclear Medicine and imaging

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3